PRGO - CIK 0001585364
PERRIGO Co plc trades as PRGO and has a market capitalization of $1.56 B, making it the #2298 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $4.25B, down 2.8% from the prior year and net income of -$1.43B. This page tracks PERRIGO Co plc through 1,356 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years PERRIGO Co plc's revenue declined from $5.28B to $4.25B, a compound annual decline rate of 2.4%. Net profit margin expanded from -76.0% to -33.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-15 |
| Insider trade (amended) | 4/A | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
Empowering consumers to proactively prevent or treat conditions that can be self-managed
Empowering consumers to proactively prevent or treat conditions that can be self-managed
Empowering consumers to proactively prevent or treat conditions that can be self-managed
The largest companies sharing PERRIGO Co plc's SEC industry classification (pharmaceutical preparations).
PERRIGO Co plc (PRGO) has a market capitalization of $1.56 B as of 2026-06-10, ranking #2298 among US-listed companies.
PERRIGO Co plc reported revenue of $4.25B for fiscal year 2025, a decrease of 2.8% year over year.
In its latest fiscal year PERRIGO Co plc reported a net loss of $1.43B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.